Zoetis (ZTS) Free Cash Flow (2012 - 2026)
Zoetis (ZTS) posted quarterly Free Cash Flow of $291.0 million for Q1 2026, down 13.65% year-over-year from $337.0 million in Q1 2025, and up 5.82% quarter-over-quarter from $275.0 million in Q4 2025.
Zoetis (ZTS) Free Cash Flow (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Free Cash Flow for 15 consecutive years, with $291.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow fell 13.65% year-over-year to $291.0 million; the TTM figure through Mar 2026 stood at $2.2 billion (down 21.01% YoY), while the FY2025 annual figure was $2.3 billion, down 22.61% from the prior year.
- Free Cash Flow improved to $291.0 million in Q1 2026 per ZTS's latest filing, from $275.0 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $1.3 billion in Q3 2025 and bottomed at -$203.0 million in Q2 2023.
- Historically, Free Cash Flow has averaged $541.2 million across 5 years, with a median of $455.0 million in 2024.
- On a YoY basis, Free Cash Flow climbed as much as 461.88% in 2023 and fell as far as 160.6% in 2023.
- Zoetis' Free Cash Flow stood at $160.0 million in 2022, then jumped by 461.88% to $899.0 million in 2023, then rose by 0.78% to $906.0 million in 2024, then slumped by 69.65% to $275.0 million in 2025, then rose by 5.82% to $291.0 million in 2026.
- Business Quant data shows ZTS's Free Cash Flow at $291.0 million in Q1 2026, $275.0 million in Q4 2025, and $1.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 137.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 538.00 Mn |
| Jun 30, 2026 | 538.00 Mn |
| Mar 31, 2026 | 291.00 Mn |
| Mar 31, 2026 | 291.00 Mn |
| Dec 31, 2025 | 275.00 Mn |
| Dec 31, 2025 | 275.00 Mn |
| Sep 30, 2025 | 1.26 Bn |
| Sep 30, 2025 | 1.26 Bn |
| Jun 30, 2025 | 409.00 Mn |
| Jun 30, 2025 | 409.00 Mn |
| Mar 31, 2025 | 337.00 Mn |
| Mar 31, 2025 | 337.00 Mn |
| Dec 31, 2024 | 906.00 Mn |
| Dec 31, 2024 | 906.00 Mn |
| Sep 30, 2024 | 950.00 Mn |
| Sep 30, 2024 | 950.00 Mn |
| Jun 30, 2024 | 639.00 Mn |
| Jun 30, 2024 | 639.00 Mn |
| Mar 31, 2024 | 455.00 Mn |
| Mar 31, 2024 | 455.00 Mn |